analyst expectations
Coverage of analyst expectations in the Nexus archive.
- Celsius Holdings stock plunges after its flagship energy drink brand posted a sales decline
Celsius Holdings' stock plunged after its flagship energy drink brand posted a sales decline. The company reported total revenue of $817.9 million in the second quarter, which missed analyst expectations by roughly $55 million.
- AstraZeneca's profit beat expectations as cancer drug sales powered growth
AstraZeneca's core earnings per share increased to $2.63 in Q2, exceeding analyst expectations of $2.48. The company attributed the growth to strong cancer drug sales and maintained its full-year and 2030 outlooks.
- Honeywell Technologies raised its profit forecast but missed earnings expectations in its debut standalone results
Honeywell Technologies increased its adjusted EPS outlook to $8.05–$8.35 but failed to meet analyst expectations for the quarter. The automation company's debut standalone results showed a raised profit forecast despite missing earnings targets.
- Ulta Beauty beats earnings estimates and raises its profit outlook
Ulta Beauty reported fiscal first-quarter earnings of $7.74 per share, exceeding analyst expectations and raising its profit outlook.
- Carnival stock sinks after summer profit forecast disappoints
Carnival's stock declined following a summer profit forecast that fell short of analyst expectations, despite the cruise operator reporting record second-quarter revenue and adjusted net income.